论文部分内容阅读
动脉粥样硬化被认为是炎症性疾病,C-反应蛋白(CRP)水平与心血管风险有关,一些研究表明他汀类药物预防原发及继发性卒中可以降低CRP水平。一项大规模临床试验表明心绞痛或非Q波心肌梗死患者人院24～96h使用大剂量阿托伐他汀可以减少缺血事件的再发,但该药对住院期间急性炎症的效果仍需进一步探讨。本研究的主要目的旨在评估急性冠
Atherosclerosis is considered an inflammatory disease and C-reactive protein (CRP) levels are associated with cardiovascular risk. Some studies suggest that statins prevent CRP levels from decreasing both primary and secondary stroke. A large-scale clinical trial showed that large doses of atorvastatin can reduce the recurrence of ischemic events in hospitalized patients with angina pectoris or non-Q wave myocardial infarction 24 to 96 hours, but the effect of the drug on acute inflammation during hospitalization is still to be further explored . The main purpose of this study was to evaluate acute crowns